Literature DB >> 22801036

Post-translational regulation of sphingosine kinases.

Huasheng Chan1, Stuart M Pitson.   

Abstract

Sphingosine kinases (SKs) catalyse the conversion of sphingosine to sphingosine 1-phosphate (S1P), a signalling lipid that is involved in a plethora of cellular processes including proliferation, apoptosis, calcium homeostasis, angiogenesis, vascular and neuronal maturation, cell migration and immune responses. Over the last few years, it has become clear that SKs are subject to various forms of post-translational regulation which play important roles in the function of these enzymes. Moreover, dysregulation of SKs has been implicated in many pathological conditions, such as cancer. Here we review the various mechanisms of post-translational regulation of the SKs with the view that such knowledge may lead to the development of therapeutic strategies to modulate the activities of these enzymes in the treatment of cancer and a range of other conditions. This article is part of a Special Issue entitled Advances in Lysophospholipid Research.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801036     DOI: 10.1016/j.bbalip.2012.07.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jin Yu; Keith T Borg; Yusuf A Hannun; Richard L Proia; Mark S Kindy; Tatyana I Gudz
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

Review 2.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

Review 3.  Sources, metabolism, and regulation of circulating sphingosine-1-phosphate.

Authors:  Monika Książek; Marta Chacińska; Adrian Chabowski; Marcin Baranowski
Journal:  J Lipid Res       Date:  2015-05-26       Impact factor: 5.922

4.  Role of sphingosine kinase 1 and sphingosine-1-phosphate in CD40 signaling and IgE class switching.

Authors:  Eugene Y Kim; Jamie L Sturgill; Nitai C Hait; Dorit Avni; Evelyn C Valencia; Michael Maceyka; Santiago Lima; Jeremy Allegood; Wei-Ching Huang; Shijun Zhang; Sheldon Milstien; Daniel Conrad; Sarah Spiegel
Journal:  FASEB J       Date:  2014-07-01       Impact factor: 5.191

5.  Both Sphingosine Kinase 1 and 2 Coordinately Regulate Cathelicidin Antimicrobial Peptide Production during Keratinocyte Differentiation.

Authors:  Kyong-Oh Shin; Kun Pyo Kim; Yunhi Cho; Min-Kyung Kang; Young-Hee Kang; Yong-Moon Lee; Hiroko Ikushiro; Mami Yokota; Takato Yano; Sung Jay Choe; Eung Ho Choi; Chae Jin Lim; Keedon Park; Walter M Holleran; Kyungho Park; Yoshikazu Uchida
Journal:  J Invest Dermatol       Date:  2018-09-15       Impact factor: 8.551

6.  A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.

Authors:  Melissa R Pitman; Jason A Powell; Carl Coolen; Paul A B Moretti; Julia R Zebol; Duyen H Pham; John W Finnie; Anthony S Don; Lisa M Ebert; Claudine S Bonder; Briony L Gliddon; Stuart M Pitson
Journal:  Oncotarget       Date:  2015-03-30

7.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 8.  Angiogenesis in the atherosclerotic plaque.

Authors:  Caroline Camaré; Mélanie Pucelle; Anne Nègre-Salvayre; Robert Salvayre
Journal:  Redox Biol       Date:  2017-02-01       Impact factor: 11.799

Review 9.  Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

10.  Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse.

Authors:  Fiona H Greig; Katrin Nather; Margaret D Ballantyne; Zeshan H Kazi; Husam Alganga; Marie-Ann Ewart; Karolina E Zaborska; Bracy Fertig; Nigel J Pyne; Susan Pyne; Simon Kennedy
Journal:  Eur J Pharmacol       Date:  2018-10-23       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.